Phlorizin pretreatment reduces acute renal toxicity in a mouse model for diabetic nephropathy

Journal of Biological Chemistry

Volumn 288, Issue 38, 2013, Pages 27200-27207

  Brouwers, Bas ^a   Pruniau, Vincent P E G ^a   Cauwelier, Elisa J G ^a   Schuit, Frans ^b   Lerut, Evelyne ^c   Ectors, Nadine ^c   Declercq, Jeroen ^a   Creemers, John W M ^a  

^a Department of Human Genetics   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TOXICITY; CO-TRANSPORTERS; DIABETIC NEPHROPATHY; GASTRIC EMPTYING; MOUSE MODELS; PRE-TREATMENT; STREPTOZOTOCIN; TOXIC SIDE EFFECTS;

CYTOTOXICITY; DISEASES; MAMMALS;

TOXICITY;

CREATININE; GHRELIN; GLUCOSE TRANSPORTER 2; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITROGEN; PHLORIZIN; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 2; UREA;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH DISTENSION; STOMACH EMPTYING; STREPTOZOCIN DIABETES; UPREGULATION; UREA NITROGEN BLOOD LEVEL;

DIABETES; DIABETIC NEPHROPATHY; GASTRIC DILATATION; GLUCOSE; GLUCOSE TRANSPORT; KIDNEY; MOUSE; PHLORIZIN; SGLT; STREPTOZOTOCIN;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; INSULIN-SECRETING CELLS; KIDNEY; MALE; MICE; PHLORHIZIN; SODIUM-GLUCOSE TRANSPORTER 1; STREPTOZOCIN;

EID: 84884536502     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.469486     Document Type: Article

References (54)

1. Breyer, M. D., Böttinger, E., Brosius, F. C., 3rd, Coffman, T. M., Harris, R. C., Heilig, C. W., and Sharma, K., AMDCC (2005) Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 16, 27-45
2. Brosius, F. C., 3rd, Alpers, C. E., Bottinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., Levi, M., McIndoe, R. A., Sharma, K., Smithies, O., Susztak, K., Takahashi, N., and Takahashi, T., Animal Models of Diabetic Complications Consortium (2009) Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 20, 2503-2512
3. Tesch, G. H., and Allen, T. J. (2007) Rodent models of streptozotocininduced diabetic nephropathy. Nephrology (Carlton) 12, 261-266
4. Lenzen, S. (2008) The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 51, 216-226
5. Weiss, R. B. (1982) Streptozocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treat. Rep. 66, 427-438
6. Rerup, C. C. (1970) Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22, 485-518
7. Tay, Y.-C., Wang, Y., Kairaitis, L., Rangan, G. K., Zhang, C., and Harris, D. C. H. (2005) Can murine diabetic nephropathy be separated from superimposed acute renal failure? Kidney Int. 68, 391-398
8. Kraynak, A. R., Storer, R. D., Jensen, R. D., Kloss, M. W., Soper, K. A., Clair, J. H., DeLuca, J. G., Nichols, W. W., and Eydelloth, R. S. (1995) Extent and persistence of streptozotocin-inducedDNAdamage and cell proliferation in rat kidney as determined by in vivo alkaline elution and BrdUrd labeling assays. Toxicol. Appl. Pharmacol. 135, 279-286
9. Palm, F., Ortsäter, H., Hansell, P., Liss, P., and Carlsson, P.-O. (2004) Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocindiabetic rat model. Diabetes Metab. Res. Rev. 20, 452-459
10. Kume, E., Fujimura, H., Matsuki, N., Ito, M., Aruga, C., Toriumi, W., Kitamura, K., and Doi, K. (2004) Hepatic changes in the acute phase of streptozotocin (SZ)-induced diabetes in mice. Exp. Toxicol. Pathol. 55, 467-480
11. Muller, Y. D., Golshayan, D., Ehirchiou, D., Wyss, J. C., Giovannoni, L., Meier, R., Serre-Beinier, V., Puga Yung, G., Morel, P., Bühler, L. H., and Seebach, J. D. (2011) Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells. Diabetes 60, 2331-2340
12. Johnston, A. P. W., Campbell, J. E., Found, J. G., Riddell, M. C., and Hawke, T. J. (2007) Streptozotocin induces G2 arrest in skeletal muscle myoblasts and impairs muscle growth in vivo. Am. J. Physiol. Cell Physiol. 292, C1033-C1040
13. Wold, L. E., and Ren, J. (2004) Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinasedependent oxidative stress mechanism. Biochem. Biophys. Res. Commun. 318, 1066-1071
14. Fu, Y., Maianu, L., Melbert, B. R., and Garvey, W. T. (2004) Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol. Dis. 32, 182-190
15. Stanley, W. C., Lopaschuk, G. D., Hall, J. L., and McCormack, J. G. (1997) Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc. Res. 33, 243-257
16. Ehrenkranz, J. R. L., Lewis, N. G., Kahn, C. R., and Roth, J. (2005) Phlorizin: a review. Diabetes Metab. Res. Rev. 21, 31-38
17. Schnedl, W. J., Ferber, S., Johnson, J. H., and Newgard, C. B. (1994) STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43, 1326-1333
18. Santer, R., and Calado, J. (2010) Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target. Clin. J. Am. Soc. Nephrol. 5, 133-141
19. Martindale, W., and Westcott, W. (1989) Martindale: the Extra Pharmacopoeia, 29th Ed., p. 649, Pharmaceutical Press, London
20. Kim, E. M., Grace, M. K., Welch, C. C., Billington, C. J., and Levine, A. S. (1999) STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. Am. J. Physiol. 276, R1320-R1326
21. Mizuno, T. M., Makimura, H., Silverstein, J., Roberts, J. L., Lopingco, T., and Mobbs, C. V. (1999) Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin. Endocrinology 140, 4551-4557
22. Kume, E., Ohmachi, Y., Itagaki, S., Tamura, K., and Doi, K. (1994) Hepatic changes of mice in the subacute phase of streptozotocin (SZ)-induced diabetes. Exp. Toxicol. Pathol. 46, 368-374
23. Ravelli, A. M. (1995) Gastrointestinal function in chronic renal failure. Pediatr. Nephrol. 9, 756-762
24. Hirako, M., Kamiya, T., Misu, N., Kobayashi, Y., Adachi, H., Shikano, M., Matsuhisa, E., and Kimura, G. (2005) Impaired gastric motility and its relationship to gastrointestinal symptoms in patients with chronic renal failure. J. Gastroenterol. 40, 1116-1122
25. Strid, H., Simrén, M., Stotzer, P.-O., Abrahamsson, H., and Björnsson, E. S. (2004) Delay in gastric emptying in patients with chronic renal failure. Scand. J. Gastroenterol. 39, 516-520
26. Belangero, V. M., and Collares, E. F. (1998) Gastric emptying of liquids in rats with acute renal insufficiency. Arq. Gastroenterol. 35, 278-282
27. Yoshimoto, A., Mori, K., Sugawara, A., Mukoyama, M., Yahata, K., Suganami, T., Takaya, K., Hosoda, H., Kojima, M., Kangawa, K., and Nakao, K. (2002) Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J. Am. Soc. Nephrol. 13, 2748-2752
28. Aygen, B., Dogukan, A., Dursun, F. E., Aydin, S., Kilic, N., Sahpaz, F., and Celiker, H. (2009) Ghrelin and obestatin levels in end-stage renal disease. J. Int. Med. Res. 37, 757-765
29. Jarkovská, Z., Hodková, M., Sazamová, M., Rosická, M., Dusilová-Sulková, S., Marek, J., Justová, V., Lacinová, Z., Haluzík, M., Haas, T., and Krsek, M. (2005) Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis. Growth Horm. IGF Res. 15, 369-376
30. Asakawa, A., Inui, A., Fujimiya, M., Sakamaki, R., Shinfuku, N., Ueta, Y., Meguid, M. M., and Kasuga, M. (2005) Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54, 18-24
31. Kinne, R. K. H., and Castaneda, F. (2011) SGLT inhibitors as new therapeutic tools in the treatment of diabetes. Handb. Exp. Pharmacol. 105-126
32. Yoshikawa, T., Inoue, R., Matsumoto, M., Yajima, T., Ushida, K., and Iwanaga, T. (2011) Comparative expression of hexose transporters (SGLT1, GLUT1, GLUT2 and GLUT5) throughout the mouse gastrointestinal tract. Histochem. Cell Biol. 135, 183-194
33. Bolzán, A. D., and Bianchi, M. S. (2002) Genotoxicity of streptozotocin. Mutat. Res. 512, 121-134
34. Marks, J., Carvou, N. J. C., Debnam, E. S., Srai, S. K., and Unwin, R. J. (2003) Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane. J. Physiol. 553, 137-145
35. Havasi, A., and Borkan, S. C. (2011) Apoptosis and acute kidney injury. Kidney Int. 80, 29-40
36. Urbschat, A., Obermüller, N., and Haferkamp, A. (2011) Biomarkers of kidney injury. Biomarkers 16, Suppl. 1, S22-S30
37. Waring, W. S., and Moonie, A. (2011) Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury. Clin. Toxicol. (Phila) 49, 720-728
38. Ko, G. J., Grigoryev, D. N., Linfert, D., Jang, H. R., Watkins, T., Cheadle, C., Racusen, L., and Rabb, H. (2010) Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am. J. Physiol. Renal Physiol. 298, F1472-F1483
39. García, A., Erdman, S., Sheppard, B. J., Murphy, J. C., and Fox, J. G. (2001) Gastric dilatation syndrome associated with chronic nephropathy, hypergastrinemia, and gastritis in mice exposed to high levels of environmental antigens. Comp. Med. 51, 262-267
40. Campanile, N., Rood, P. P. P. M., Yeh, P., Casu, A., Bottino, R., and Cooper, D. K. C. (2007) Acute gastric dilatation after porcine islet transplantation in a cynomolgus monkey - case history and review of the literature. Xenotransplantation 14, 265-270
41. Tal, M. G., Hirshberg, B., Neeman, Z., Bunnell, D., Soleimanpour, S., Bacher, J., Patterson, N., Chang, R., and Harlan, D. M. (2004) Induction of diabetes in nonhuman primates by means of temporary arterial embolization and selective arterial injection of streptozotocin. Radiology 230, 163-168
42. Silang, R., Regalado, M., Cheng, T. H., and Wesson, D. E. (2001) Prokinetic agents increase plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying. Am. J. Kidney Dis. 37, 287-293
43. Ross, E. A., and Koo, L. C. (1998) Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients. Am. J. Kidney Dis. 31, 62-66
44. De Schoenmakere, G., Vanholder, R., Rottey, S., Duym, P., and Lameire, N. (2001) Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients. Nephrol. Dial. Transplant. 16, 1850-1855
45. Janssen, P., Vanden Berghe, P., Verschueren, S., Lehmann, A., Depoortere, I., and Tack, J. (2011) Review article: the role of gastric motility in the control of food intake. Aliment. Pharmacol. Ther. 33, 880-894
46. Zhang, R.-X., Wang, X.-Y., Chen, D., and Huizinga, J. D. (2011) Role of interstitial cells of Cajal in the generation and modulation of motor activity induced by cholinergic neurotransmission in the stomach. Neurogastroenterol. Motil. 23, e356-e371
47. Fujimiya, M., Ataka, K., Asakawa, A., Chen, C.-Y., Kato, I., and Inui, A. (2011) Ghrelin, des-acyl ghrelin and obestatin on the gastrointestinal motility. Peptides 32, 2348-2351
48. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660
49. Fujino, K., Inui, A., Asakawa, A., Kihara, N., Fujimura, M., and Fujimiya, M. (2003) Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J. Physiol. 550, 227-240
50. Fujimiya, M., Ataka, K., Asakawa, A., Chen, C.-Y., Kato, I., and Inui, A. (2012) Regulation of gastroduodenal motility: acyl ghrelin, des-acyl ghrelin and obestatin and hypothalamic peptides. Digestion 85, 90-94
51. Wright, E. M. (2001) Renal Na (β)-glucose cotransporters. Am. J. Physiol. Renal Physiol. 280, F10-F18
52. Barcelona, S., Menegaz, D., and Díez-Sampedro, A. (2012) Mouse SGLT3a generates proton-activated currents but does not transport sugar. Am. J. Physiol. Cell Physiol. 302, C1073-C1082
53. Mather, A., and Pollock, C. (2010) Renal glucose transporters: novel targets for hyperglycemia management. Nat. Rev. Nephrol. 6, 307-311
54. Karunanayake, E. H., Hearse, D. J., and Mellows, G. (1976) Streptozotocin: its excretion and metabolism in the rat. Diabetologia 12, 483-488